SFEE Diet Management for Gestational Diabetes Mellitus
SFEE
A Parallel-Group Controlled Clinical Study to Evaluate the Efficacy of Self-Family-Environment Empowerment (SFEE) Diet Management Intervention in Improving Outcomes for Pregnant Women With Gestational Diabetes Mellitus
2 other identifiers
interventional
64
1 country
1
Brief Summary
This study aims to evaluate the impact of the Self-Family-Environment Empowerment (SFEE) diet management intervention on glycemic control, maternal outcomes, and dietary adherence in pregnant women with gestational diabetes mellitus (GDM).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
March 31, 2024
CompletedFirst Submitted
Initial submission to the registry
November 23, 2024
CompletedFirst Posted
Study publicly available on registry
November 27, 2024
CompletedNovember 27, 2024
November 1, 2024
1 year
November 23, 2024
November 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Glycemic Control (Fasting Blood Glucose Levels)
Change in fasting blood glucose levels (measured in mmol/L) from baseline to the end of the 3-month intervention period. This measure evaluates the effectiveness of the SFEE diet management intervention in improving blood glucose regulation in gestational diabetes mellitus.
Baseline and 3 months post-intervention
Glycemic Control (HbA1c Levels)
Change in HbA1c levels (measured in %) from baseline to the end of the 3-month intervention period. This measure assesses the long-term blood sugar control improvements resulting from the SFEE diet management intervention compared to standard dietary advice.
Baseline and 3 months post-intervention
Secondary Outcomes (3)
Dietary Adherence
Baseline and 3 months post-intervention
GDM Knowledge
Baseline and 3 months post-intervention
Perceived Social Support
Baseline and 3 months post-intervention
Study Arms (2)
SFEE Diet Management Group ( Experimental Arm)
EXPERIMENTALParticipants in this group received the Self-Family-Environment Empowerment (SFEE) diet management intervention, which included: Self-empowerment: Goal-setting, dietary planning, and evaluation. Family empowerment: Emotional support and supervision of dietary practices. Environmental empowerment: Peer group interaction, education, and support through WeChat groups. Routine nursing care was also provided alongside the intervention.
Control Group
ACTIVE COMPARATORParticipants in this group received routine nursing care for gestational diabetes management, including: Medication guidance, dietary education using guidance charts, exercise plans, and self-monitoring. Dietary plans were customized based on individual patient needs, but no additional empowerment strategies (e.g., SFEE) were implemented.
Interventions
A structured diet management program designed to improve glycemic control, dietary adherence, and maternal outcomes. It includes: Self-empowerment: Goal-setting, dietary planning, and evaluation. Family empowerment: Emotional support and supervision. Environmental empowerment: Peer group interaction and education via WeChat groups and in-person meetings.
Routine nursing care, including dietary education, exercise planning, and self-monitoring for gestational diabetes management.
Eligibility Criteria
You may qualify if:
- Diagnosed with gestational diabetes mellitus (GDM) based on the International Association of Diabetes and Pregnancy Study Groups (IADPSG) criteria.
- Aged 18-45 years.
- Pregnant women between 24-28 weeks of gestation at the time of enrollment.
- Able to provide informed consent.
- Access to a mobile phone and internet for study communication and follow-up.
You may not qualify if:
- Pregnant women with complications such as placental abruption, miscarriage, or induced abortion during the study period.
- Those unable to give informed consent or adhere to the intervention due to medical or personal reasons.
- History of severe medical conditions or other factors that might interfere with study participation (e.g., severe mental health conditions).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ji Jinglead
Study Sites (1)
The First Hospital of Shanxi Medical University
Taiyuan, Shanxi, 030001, China
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Li Jun, Doctorate
The First Affiliated Hospital of Shanxi Medical University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Outcome assessors were blinded to minimize bias during data collection and analysis. Participants and care providers were not masked due to the nature of the intervention.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Head of Nurse Department
Study Record Dates
First Submitted
November 23, 2024
First Posted
November 27, 2024
Study Start
March 1, 2023
Primary Completion
March 1, 2024
Study Completion
March 31, 2024
Last Updated
November 27, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share
Individual participant data (IPD) will not be shared as there is no provision for data sharing in the current study design, and ethical approval for data sharing has not been obtained. Researchers requiring data can contact the corresponding author for potential collaboration or data access requests in compliance with institutional and ethical guidelines